M Ahmed

Majlis Nusrat Jehan physician, father, Infectious Diseases, (Love for All, Hatred for None) #Ahmadi #Muslim DP ~ Ather Ahmed, Muneef Rehan & Daniya Rehan

[M Ahmed @marehan777]

Hilarious must watch video
Can’t believe IQ level of these guys

[#ahmadiyyafactcheckblog @Ahmadiyyafacts]

Oh #Ahmadis. We won’t stop until the Mirza family business is shut down!!!

#ahmadiyya #ahmadiyyafactcheckblog #messiahhascome #ahmadiyyat #trueislam #ahmadianswers #mirzaghulamahmad #qadiani #qadianism

[Miguel Ángel Amor @Miguelamorg]

📄Revisión narrativa 2026: Combinaciones de cefepime aprobadas y en investigación

👉Cefepime asociado a enmetazobactam, taniborbactam, zidebactam y nacubactam
👉Cambio paradigma: alta afinidad a PBP2 y PBP3
👉Algoritmo de decisión y tabla comparativa

https://t.co/RP4mWMaPFi

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Static vs. cidal: it’s not complex; it’s simply incorrect
@BradSpellberg et Al
Honored to be part of this amazing group who challenges dogmas and debunk ID myths #idxposts
https://t.co/4bldEnYTK5

[Mahdi Aleid | مهدي العيد @mahdi_aleid]

Understanding MICs and CLSI breakpoints is one of the most important skills in infectious diseases and antimicrobial stewardship.

A culture report should never stop at:
“Susceptible.”

Instead, we should ask:
• What is the MIC?
• Is it close to the breakpoint?
• Is the dosing optimized?
• Does the patient’s condition affect clinical success?

A great reminder that not all “susceptible” results are equally strong clinically.

#ClinicalPharmacy #InfectiousDiseases #AntimicrobialStewardship #CLSI #MIC #IDPharmacist #PharmacyResidency #CriticalCare #HealthcareEducation

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕💥🔴 Multicenter Cohort Study
Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections #IDXposts https://t.co/vjO05KSeca

[Paul Sax @PaulSaxMD]

Two weeks on ID consults → some highlights:
• Staph aureus from the urinary tract (yes, really)
• “Explosive pleuritis” (still a great name)
• Sinus fungal balls that aren’t so scary
• Poor CD4 recovery in HIV
• And why strep taxonomy = chaos
Link in reply ...

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

In vitro activity of β-lactams (amoxicillin piperacillin, imipenem, meropenem and ceftobiprole)against contemporary Enterococcus faecalis clinical isolates France
Amox: 100% S
PiP: 91% S
MER: 97.5% S
MER: 75.5% S
Cefto: 86% S
https://t.co/FSKSKQXooU

[Razi @StudentOfAhmad]

Non-Ahmadi Muslims are speaking up against Adnan and Imtiaz for failing the 72 sects

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥 💥Late-Breakers |COBRA RCT
1-day of antibiotic treatment after adequate endoscopic biliary drainage is non-inferior to 4-7 days in adults with acute cholangitis.
💡 Shorter is better+source control
Practice-changing? #ESCMIDGlobal2026

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

There is no role for adjunctive clindamycin in SAB
No sub-cohorts with benefit shown
Clindamycin likely to be harmful in patients with SAB
Microbiome impact on gut anaerobes? #ESCMIDGlobal2026

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕🔥SCOUT RCT*
The RCT found that Nitrofurantoin was the most effective treatment and single-dose fosfomycin the least effective treatment for UTIs #ESCMIDGlobal2026
https://t.co/gNtrZZXKfl

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Hot 🔥 in ID
Macrolides for hospital treatment of CAP: to add or not to add ?!
CAP-START RCT ❌
ACCESS RCT ✅
Awaiting REMAP-CAP,the debate continues! #IDXposts

[NEJM @NEJM]

𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀

Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong evidence to support their use — in fact, they have presaged a mini-revolution in how type 2 diabetes is managed. 👉 https://t.co/D0XSLv7U8n

Tirzepatide was the first dual GLP-1 and glucose-dependent insulinotropic peptide receptor agonist approved for the treatment of type 2 diabetes on the basis of the SURPASS-1 (Tirzepatide [LY3298176] in Participants with Type 2 Diabetes Not Controlled with Diet and Exercise Alone) trial, a randomized, placebo-controlled trial of tirzepatide (administered in weekly doses of 5 mg, 10 mg, or 15 mg) paired with metformin for treatment of type 2 diabetes (seen in figure). Tirzepatide reduced glycated hemoglobin levels by as much as 2 percentage points and was superior to placebo at all dose levels. At 40 weeks, nearly 90% of participants had glycated hemoglobin levels of less than 7.0%, a change that was associated with profound weight loss.

Read the Review Article “GLP-1 Receptor Agonists” by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, from @TuftsMedSchool and the Maine Medical Center Institute for Research: https://t.co/D0XSLv7U8n

[Rony @Ronycoder]

Instead of watching an hour of Netflix, watch this 2-hour Stanford lecture on AI careers. It will teach you more about winning in the AI race than all the AI content you’ve scrolled past this year.

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

It remains unclear if CzIE based on in vitro testing translates to cefazolin treatment failure for patients.
🆕⚡🟢 Multi-center retrospective cohort study
Cefazolin inoculum effect and cefazolin microbiological treatment failure in serious MSSA infections
In this multi-centre retrospective cohort study of 259 patients with serious MSSA infection treated with cefazolin, the CzIE prevalence was 35.5%. Although all-cause mortality was similar between CzIE positive and negative group, CzIE was associated with a higher risk of microbiological treatment failure with adjusted sHR of 3.12 (95% CI 1.38 to 7.08, p=0.0065). https://t.co/yGo1uuRzqN

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

A “penicillin allergy” label is not an absolute contraindication to using piperacillin–tazobactam.

[JAMA @JAMA_current]

Pertussis, or #WhoopingCough, is a common cause of severe and prolonged cough in adults in the US.

💡 Learn more about the epidemiology, transmission, and risk factors for pertussis in this JAMA Insights: https://t.co/6a5gP0ZcAK

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Missed the biggest ID research of 2025?Here’s your chance to catch up!
🆕🔥Year in Review –Top ID Articles from 2025!
All the most important infectious diseases research in one place!
🤝Huge appreciation to @IDstewardship for helping bring this together!
🔗https://t.co/UCe9OgYpzQ

[NEJM @NEJM]

The number of referrals to ID doctors for latent tuberculosis has exploded. What happened? Read the latest from @PaulSaxMD: https://t.co/hvPsXaXhiQ

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Why am I not surprised?
IDSA has just endorsed the Surviving Sepsis Campaign (SSC) 2026 guidelines (adult & pediatric). @BradSpellberg @PulmCrit #IDXposts https://t.co/Ejysq7jkOh

[Wataru Hayashi / 林 航 @DraWataru]

Klebsiella oxytoca...🏥👨‍⚕️👩‍⚕️